Dermatology
Conference Coverage
Two questions can help establish a diagnosis of hidradenitis suppurativa
There is no perfect outcome measure yet, but progress is being made.
Conference Coverage
Certain opioids hold promise for treating itch
Difelikefalin is the first FDA-approved treatment for uremic pruritus associated with dialysis.
Conference Coverage
Validity of commercial serologic tests for dermatomyositis still questionable
“The testing in research laboratories is not widely available and the results are often delayed by weeks to months.”
From the Journals
Prevalence of undiagnosed vitiligo is ‘remarkably high’
Current overall prevalence among adult population estimated at 1.9 million to 2.8 million in the United States.
Conference Coverage
Rosacea is in the eye of the beholder, expert says
As for treating papules and pustules with oral agents, the strongest evidence favors oral tetracyclines and isotretinoin.
Latest News
Microbiome studies among those awarded National Rosacea Society grants
Projects earning grants in 2021 include those on the ocular microbiome and genetic sequencing of Demodex mites.
Conference Coverage
Topical options for acne patients continue to expand
In 2020, clascoterone cream became the first topical androgen receptor inhibitor approved for the treatment of acne in patients aged 12 years and...
Opinion
A 73-year-old White male presented with 2 days of a very pruritic rash
The rash started on his abdomen, back, and arms and was progressing down his legs.
From the Journals
AI: Skin of color underrepresented in datasets used to identify skin cancer
“There was massive underrepresentation of skin lesion images from darker-skinned populations,” the authors wrote.
From the Journals
Contact allergens in medical devices: A cause for concern?
Despite the clinical value of medical devices, there is a potential for these products to cause adverse skin reactions in some patients.
Conference Coverage
Genotype, need for transfusion predict death in VEXAS syndrome
Among patients with a methionine-to-valine substitution in the UBA1 gene, survival was significantly worse, compared with patients with two other...